Amarin Corp. (AMRN) Receives USPTO Notice of Allowance for '145 App
- Wall Street ends higher, investors juggle Fed nerves with AI enthusiasm
- Apple in talks with Google to use generative AI in iPhones- Bloomberg
- World shares cheer China data, as central banks line up
- Oil prices climb 2% to 4-month high on lower Iraq, Saudi exports
- Meta Platforms is a new Top Pick at Mizuho, analyst sees upside to consensus
- After-hours movers: ANSYS, National CineMedia, and more
- Midday movers: Google, Pepsi rise; Boeing, Zillow fall
- Midday movers: Adobe, Zillow fall; Micron rises
- After-hours movers: Adobe Systems slumps; Rivian, Ulta Beauty gain
- Midday movers: Tesla, Nvidia fall premarket; Robinhood, Dollar General rise
Jefferies Maintains a 'Buy' on Amarin Corporation (AMRN); MARINE Patent Allowed
September 4, 2012 8:06 AM EDTJefferies maintains a 'Buy' on Amarin Corporation (NASDAQ: AMRN) price target of $28.00.
Analyst, Thomas Wei, said, "The patent office (PTO) issued a notice of allowance to the 145 MARINE application. While largely expected, we believe this is an incremental positive for AMRNs strategy to... More
Amarin (AMRN) Higher after Patent Update
August 31, 2012 12:47 PM EDTShares of Amarin Corporation plc (NASDAQ: AMRN) are higher Friday after the USPTO updated the patent status on application 13/282,145 to show it will be allowed and will be mailed Sept. 5. The '145 patent is a continuation of 12/702,889.
The Vascepa patent wins may support Vascepa... More